We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cardiac Gene Linked to Sudden Infant Death

By HospiMedica staff writers
Posted on 29 Nov 2001
A study has demonstrated that a cardiac gene is linked to sudden infant death syndrome (SIDS). More...
The study, conducted by researchers at the Mayo Clinic (Rochester, MN, USA), was published in the November 14, 2001, issue of the Journal of the American Medical Association.

Using molecular genetic testing, researchers examined tissue collected from 93 cases of SIDS or possible SIDS for a specific defect in the SCN5A gene in the heart. This gene incodes a cardiac sodium channel that acts as an electrical tunnel and controls the heart's rhythm. In two of the 93 cases, infants were found to possess SCN5A mutations. This suggests that a lethal heart rhythm disturbance may be the cause of SIDS in some cases. If further research demonstrates that 5-10% of SIDS cases may be due to such defects, it may be possible in the future to identify such at-risk infants shortly after birth by special molecular tests. Defects in the cardiac channel genes might also lead to later risk of death by congenital long QT syndrome or Brugada syndrome in adolescence if a child escapes death by SIDS during infancy.

"We're just starting to be able to identify those infants that may be at risk for SIDS and take steps to prevent the incidence of death,” said Michael J. Ackerman, M.D., a pediatric cardiologist at Mayo Clinic. "This step is one of many that could eventually prevent SIDS.




Related Links:
JAMA
Mayo Clinic

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.